HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of alfuzosin on female primary bladder neck obstruction.

Abstract
Our objective was to assess the effect of the selective alpha(1)-blocker alfuzosin on urodynamic parameters and quality of life in female patients with primary bladder neck obstruction (PBNO). Twenty-five women identified as having PBNO were included in the study. After the initial assessment of urodynamic parameters and bother score index, all patients were treated with alfuzosin 5 mg twice daily for 8 weeks. After this period of time, the patients were reassessed with the same methodology as pretreatment. Symptoms subjectively improved, and patients' satisfaction significantly increased in 64% of the patients (16 out of 25). Most urodynamic parameters were also significantly improved after treatment with alfuzosin. Alfuzosin significantly improved urodynamic parameters and alleviated bother score in almost two thirds of patients with PBNO and can be an effective first-line treatment of this situation.
AuthorsA Athanasopoulos, K Gyftopoulos, K Giannitsas, P Perimenis
JournalInternational urogynecology journal and pelvic floor dysfunction (Int Urogynecol J Pelvic Floor Dysfunct) Vol. 20 Issue 2 Pg. 217-22 (Feb 2009) England
PMID18982236 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Adrenergic alpha-Antagonists
  • Quinazolines
  • alfuzosin
Topics
  • Adrenergic alpha-Antagonists (pharmacology, therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Patient Satisfaction
  • Prospective Studies
  • Quality of Life
  • Quinazolines (pharmacology, therapeutic use)
  • Treatment Outcome
  • Urinary Bladder Neck Obstruction (complications, drug therapy)
  • Urination Disorders (drug therapy, etiology)
  • Urodynamics (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: